Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
- Status
- RECRUITING
- Phase
- N/A
177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Intestinal Akkermansia Muciniphila in Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
- Status
- COMPLETED
- Phase
- PHASE1
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
- Status
- RECRUITING
- Phase
- PHASE2
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of INKmune in Patients With mCRPC (CaRe Prostate)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2